LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

<
<<
Previous
Page 1 of 483
Next
>>
>
1 to 25 of 12072 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	Alpelisib	0.04	uM	LJP5	3	N06	72	hr	1334	4053	3970	1.0207	1.0311
BT-20	XMD11-85h	0.04	uM	LJP6	3	P24	72	hr	1334	3623	3970	0.9124	0.8680
BT-20	GDC-0980	0.04	uM	LJP5	3	K24	72	hr	1334	2402	3970	0.6049	0.4049
BT-20	KIN001-043	0.04	uM	LJP6	3	C12	72	hr	1334	4000	3970	1.0073	1.0110
BT-20	A443654	0.04	uM	LJP6	3	I24	72	hr	1334	3434	3970	0.8648	0.7963
BT-20	OSI-027	0.04	uM	LJP6	3	E12	72	hr	1334	4090	3970	1.0300	1.0452
BT-20	SNS-032	0.04	uM	LJP6	3	H18	72	hr	1334	3825	3970	0.9633	0.9447
BT-20	Sigma A6730	0.04	uM	LJP5	3	B24	72	hr	1334	3708	3970	0.9338	0.9003
BT-20	NVP-AEW541	0.04	uM	LJP5	3	E18	72	hr	1334	4326	3970	1.0894	1.1347
BT-20	AT-7519	0.04	uM	LJP6	3	K06	72	hr	1334	3548	3970	0.8935	0.8396
BT-20	BI-2536	0.04	uM	LJP6	3	D18	72	hr	1334	709	3970	0.1786	-0.2373
BT-20	Luminespib	0.04	uM	LJP5	3	H18	72	hr	1334	944	3970	0.2377	-0.1482
BT-20	Afatinib	0.04	uM	LJP6	3	G24	72	hr	1334	2983	3970	0.7512	0.6253
BT-20	AZD 5438	0.04	uM	LJP6	3	J06	72	hr	1334	3422	3970	0.8618	0.7918
BT-20	AZD8330	0.04	uM	LJP5	3	G24	72	hr	1334	3080	3970	0.7756	0.6621
BT-20	BMS345541	0.04	uM	LJP6	3	D06	72	hr	1334	4123	3970	1.0383	1.0577
BT-20	AZD-6482	0.04	uM	LJP5	3	I06	72	hr	1334	4014	3970	1.0109	1.0163
BT-20	Alvocidib	0.04	uM	LJP6	3	A18	72	hr	1334	3014	3970	0.7590	0.6370
BT-20	Barasertib	0.04	uM	LJP5	3	D12	72	hr	1334	3767	3970	0.9487	0.9227
BT-20	AZD7762	0.04	uM	LJP6	3	L06	72	hr	1334	3724	3970	0.9378	0.9063
BT-20	SB590885	0.04	uM	LJP5	3	L18	72	hr	1334	4414	3970	1.1116	1.1681
BT-20	PIK-93	0.04	uM	LJP5	3	K18	72	hr	1334	4424	3970	1.1141	1.1719
BT-20	AZD8055	0.04	uM	LJP6	3	A12	72	hr	1334	2267	3970	0.5709	0.3537
BT-20	WH-4-025	0.04	uM	LJP5	3	O12	72	hr	1334	3508	3970	0.8834	0.8244
BT-20	HG-6-64-01	0.04	uM	LJP6	3	M06	72	hr	1334	4264	3970	1.0738	1.1112

<
<<
Previous
Page 1 of 483
Next
>>
>
1 to 25 of 12072 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)